Sense Biodetection

Recent Finacing

Series B

Recent Raise

$15M

Sense Biodetection develops the Veros instrument-free rapid molecular amplification platform producing disposable, handheld point-of-care tests (initially COVID-19) and scalable manufacturing for decentralized infectious disease diagnostics.

Founded 2014

Oxfordshire, United Kingdom

51-100

Private

sense-bio.com

Highlights

Focus Areas

Health Care

Health Diagnostics

Medical Device

Recent Investors

Financials

$80.8M

Total Raised

3

Funding rounds

6

Investors

Team

Upgrade to view the team

See the team members at Sense Biodetection.